Article
Polymorphisms in histone deacetylases improve the predictive value of IL-28B for chronic hepatitis C therapy.
Genes and immunity - 1 Jan 2000
López-Rodríguez R, Hernández-Bartolomé Á, Borque M J, Rodríguez-Muñoz Y, Martín-Vílchez S, Trapero-Marugán M, García-Buey L, Muñoz de Rueda P, Rodrigo L, Vidal-Castiñeira J R, Salmerón J, Moreno-Otero R, Sanz-Cameno P
Abstract excerpt
Histone deacetylases (HDACs) influence many cellular processes, including the modulation of signal transducer and activator of transcription activity (STAT) in response to interferon (IFN). To identify genetic markers that help optimize the IL-28B prediction of chronic hepatitis C (CHC) sustained virological response (SVR), we evaluated 27 single-nucleotide polymorphisms (SNPs) in HDAC1-11. Three SNPs, rs3778216,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
